Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,918 | -32,184 | -38,144 | -26,422 | -13,266 |
| Depreciation Amortization | -2,587 | -7,475 | -5,062 | -3,115 | -1,578 |
| Income taxes - deferred | N/A | 155 | 0 | 0 | N/A |
| Accounts receivable | 123 | 225 | 168 | 106 | -277 |
| Accounts payable and accrued liabilities | -3,818 | 6,519 | 2,490 | -3,000 | -4,745 |
| Other Working Capital | -10,897 | -49,233 | -23,999 | -19,443 | -13,663 |
| Other Operating Activity | 7,407 | 2,981 | 4,506 | 7,631 | 7,377 |
| Operating Cash Flow | $-27,690 | $-79,012 | $-60,041 | $-44,243 | $-26,152 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,543 | -55,072 | 57,516 | 58,050 | 28,443 |
| PPE Investments | -19 | -487 | -373 | -372 | -93 |
| Investing Cash Flow | $-2,562 | $-55,559 | $57,143 | $57,678 | $28,350 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,425 | -3,425 | -3,425 | -1,200 |
| Common Stock Issued | 17,579 | 166,696 | 11,937 | 10,736 | N/A |
| Other Financing Activity | 1,772 | 1,851 | 0 | 0 | 113 |
| Financing Cash Flow | $19,351 | $165,122 | $8,512 | $7,311 | $-1,087 |
| Exchange Rate Effect | -4 | 8 | -9 | -46 | -22 |
| Beginning Cash Position | 44,189 | 13,630 | 13,630 | 13,630 | 13,630 |
| End Cash Position | 33,284 | 44,189 | 19,235 | 34,330 | 14,719 |
| Net Cash Flow | $-10,905 | $30,559 | $5,605 | $20,700 | $1,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,690 | -79,012 | -60,041 | -44,243 | -26,152 |
| Capital Expenditure | -19 | -487 | -373 | -372 | -93 |
| Free Cash Flow | -27,709 | -79,499 | -60,414 | -44,615 | -26,245 |